Skip to main content

Advertisement

Log in

Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

To test the role of necrosis, ischemia or both in bone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 + cells and cytokines were evaluated at: T0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T3 and T4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1α) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95%CI 2.2–4.2, P < 0.01), VEGF (OR 2, 95%CI 1.1–3, P = 0.01 as above versus below median value), and SDF-1α (OR 1.6, 95%CI 1.1–2.5, P = 0.02 as above versus below median value) emerged as independent predictors of C34 + cells increase. Myocardial necrosis with simultaneous elevation of VEGF and SDF-1α causes a significant CD34 + cells mobilization in patients with cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schächinger V, Erbs S, Elsässer A et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210–1221

    Article  PubMed  Google Scholar 

  2. Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141–148

    Article  PubMed  Google Scholar 

  3. Lunde K, Solheim S, Aakhus S et al (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199–1209

    Article  PubMed  CAS  Google Scholar 

  4. Janssens S, Dubois C, Bogaert J et al (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Lancet 367:113–121

    Article  PubMed  Google Scholar 

  5. George J, Goldstein E, Abashidze S et al (2004) Circulating hematopoietic endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25:1003–1008

    Article  PubMed  CAS  Google Scholar 

  6. Leone AM, Rutella S, Bonanno G et al (2006) Endogenous G-CSF and CD34 + cell mobilization after acute myocardial infarction. Int J Cardiol 111:202–208

    Article  PubMed  Google Scholar 

  7. World Medical Association Declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35:2–3

    Article  Google Scholar 

  8. Fraker TD Jr, Fihn SD, Gibbons RJ et al (2007) 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation 116:2762–2772

    Article  PubMed  Google Scholar 

  9. Antman EM, Hand M, Armstrong PW et al (2008) 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117:296–329

    Article  PubMed  Google Scholar 

  10. Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable Angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable Angina/non–ST-elevation myocardial infarction). J Am Coll Cardiol 50:e1–e157

    Article  PubMed  Google Scholar 

  11. Tracy CM, Akhtar M, DiMarco JP et al (2006) 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians task force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517

    Article  PubMed  Google Scholar 

  12. Sutherland DR, Anderson L, Keeney M et al (1996) The ISHAGE guidelines for CD34 + cell determination by flow cytometry. International society of Hematotherapy and Graft Engineering. J Hematother 5:213–226

    Article  PubMed  CAS  Google Scholar 

  13. Valgimigli M, Rigolin GM, Cittanti C et al (2005) Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 26:1838–1845

    Article  PubMed  CAS  Google Scholar 

  14. Valgimigli M, Rigolin GM, Fucili A et al (2004) CD34 + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110:1209–1212

    Article  PubMed  CAS  Google Scholar 

  15. Werner N, Kosiol S, Schiegl T et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007

    Article  PubMed  CAS  Google Scholar 

  16. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705

    Article  PubMed  CAS  Google Scholar 

  17. Shintani S, Murohara T, Ikeda H et al (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776–2779

    Article  PubMed  CAS  Google Scholar 

  18. Wojakowski W, Tendera M, Michalowska A et al (2004) Mobilization of CD34/CXCR4 + , CD34/CD117 + , c-met + stem cells, and mononuclear cells ex pressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:3213–3220

    Article  PubMed  CAS  Google Scholar 

  19. Massa M, Rosti V, Ferrario M et al (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199–206

    Article  PubMed  CAS  Google Scholar 

  20. Leone AM, Rutella S, Bonanno G et al (2005) Mobilization of bone marrow derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26:1196–1204

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Dr Monia Monti, Dr Stefania Gambetti and Dr Laura Bristot (Medical Trials Analysis, Ferrara, Italy) for their assistance in the data collecting and laboratory tests. The study was supported by a Regional-University project of Emilia Romagna–Area IB–Innovative Research grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisa Cangiano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cangiano, E., Cavazza, C., Campo, G. et al. Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. J Thromb Thrombolysis 32, 1–8 (2011). https://doi.org/10.1007/s11239-010-0543-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-010-0543-8

Keywords

Navigation